Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Josephson

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Otolaryngologic Clinics of North America|August 1, 1989
Difficult decisions in endoscopic sinus surgeryM Friedman, J S Josephson, D W Kennedy, et al.
European Journal of Immunology|July 1, 1990
Enhanced immunogenicity of recombinant peptide fusions containing multiple copies of a heterologous T helper epitopeB Löwenadler, A M Svennerholm, M Gidlund, et al.
Peptides|March 1, 1988
Production of a biologically active variant form of recombinant human secretinH Olson, P Lind, G Pohl, et al.
Journal of Biotechnology|June 1, 1990
Differential stability of recombinant human insulin-like growth factor II in Escherichia coli and Staphylococcus aureusB Hammarberg, T Moks, M Tally, et al.
Bioscience Reports|November 1, 1984
Nucleotide sequence of the thioredoxin gene from Escherichia coliJ O Höög, H von Bahr-Lindström, S Josephson, et al.
The EMBO Journal|September 1, 1986
Production of specific antibodies against protein A fusion proteinsB Löwenadler, B Nilsson, L Abrahmsén, et al.
Biotechnology and Applied Biochemistry|June 1, 1991
Purification and characterization of recombinant human insulin-like growth factor II (IGF-II) expressed as a secreted fusion protein in Escherichia coliH Wadensten, A Ekebacke, B Hammarberg, et al.
Biochemistry|August 25, 1987
Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purificationT Moks, L Abrahmsén, E Holmgren, et al.
Uremia Investigation|January 1, 1985
Sensitivity of cortical transit and furosemide response in the diagnosis of renal obstruction. An experimental modelA Piepsz, H R Ham, F Collier, et al.
Gene|January 1, 1987
A gene fusion system for generating antibodies against short peptidesB Löwenadler, B Jansson, S Paleus, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Otolaryngologic Clinics of North America|August 1, 1989
Difficult decisions in endoscopic sinus surgeryM Friedman, J S Josephson, D W Kennedy, et al.
European Journal of Immunology|July 1, 1990
Enhanced immunogenicity of recombinant peptide fusions containing multiple copies of a heterologous T helper epitopeB Löwenadler, A M Svennerholm, M Gidlund, et al.
Peptides|March 1, 1988
Production of a biologically active variant form of recombinant human secretinH Olson, P Lind, G Pohl, et al.
Journal of Biotechnology|June 1, 1990
Differential stability of recombinant human insulin-like growth factor II in Escherichia coli and Staphylococcus aureusB Hammarberg, T Moks, M Tally, et al.
Bioscience Reports|November 1, 1984
Nucleotide sequence of the thioredoxin gene from Escherichia coliJ O Höög, H von Bahr-Lindström, S Josephson, et al.
The EMBO Journal|September 1, 1986
Production of specific antibodies against protein A fusion proteinsB Löwenadler, B Nilsson, L Abrahmsén, et al.
Biotechnology and Applied Biochemistry|June 1, 1991
Purification and characterization of recombinant human insulin-like growth factor II (IGF-II) expressed as a secreted fusion protein in Escherichia coliH Wadensten, A Ekebacke, B Hammarberg, et al.
Biochemistry|August 25, 1987
Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purificationT Moks, L Abrahmsén, E Holmgren, et al.
Uremia Investigation|January 1, 1985
Sensitivity of cortical transit and furosemide response in the diagnosis of renal obstruction. An experimental modelA Piepsz, H R Ham, F Collier, et al.
Gene|January 1, 1987
A gene fusion system for generating antibodies against short peptidesB Löwenadler, B Jansson, S Paleus, et al.
Pageof 12